We are live on ! Find out more
NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

4 hedge funds and large institutions have $13K invested in Northwest Biotherapeutics, Inc. Common stock in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more capital invested

Capital invested by funds: $10K → $13K (+$3K)

0% more funds holding

Funds holding: 4 → 4 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LDB
1
Lee, Danner & Bass
Tennessee
$5K – – –
WPP
2
Whalerock Point Partners
Rhode Island
$5K – – –
MPI
3
Mairs & Power Inc
Minnesota
$3K – – –

NWBO Hedge Fund Activity: Q4 2017 in Review

4 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. Common stock (NWBO) for Q4 2017, worth a combined $13K — up 30% from $10K a quarter earlier.

Fund positioning in NWBO was balanced in Q4 2017: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

  • 4 institutional investors held Northwest Biotherapeutics, Inc. Common stock (NWBO) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $13K of Northwest Biotherapeutics, Inc. Common stock stock for Q4 2017, up 30% quarter-over-quarter.
  • 1 fund opened new Northwest Biotherapeutics, Inc. Common stock positions in Q4 2017 and 1 closed out, a net change of 0 holders.

Based on aggregated 13F filings for Q4 2017.